Intratumoral Cancer Therapies Market

About This Presentation

Title:

Intratumoral Cancer Therapies Market

Description:

Cancer is a leading cause of global death, which nearly caused 10 million deaths in 2020. The treatment of cancer typically includes chemotherapy, hormone therapy, immunotherapy, gene therapy, radiotherapy, and targeted therapy. However, in some of the cases, patients do not respond to any of the available treatment options or develop resistance to available therapies. This creates a lacuna, which in turn creates an opportunity for the scientific community to develop a keen interest in Intratumoral Cancer Therapies that are immunotherapies and the immunization is administered directly into tumour’s through injections. By filling this lacuna of cancer treatment, immunotherapy has evolved and had come a long way with its benefits and possesses advantages over conventional cancer treatment methods, which is widely accepted. – PowerPoint PPT presentation

Number of Views:23

Slides: 11

Provided by: priyasharma1

Category: Medicine, Science & Technology

Tags:

more less

Transcript and Presenter's Notes

Title: Intratumoral Cancer Therapies Market

1
Intratumoral Cancer Therapies Market
sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Intratumoral Cancer Therapies Market Global
Scenario, Market Size, Outlook, Trend, and
Forecast, 2019 2028

Cancer is a leading cause of global death, which
nearly caused 10 million deaths in 2020. The
treatment of cancer typically includes
chemotherapy, hormone therapy, immunotherapy,
gene therapy, radiotherapy, and targeted therapy.
However, in some of the cases, patients do not
respond to any of the available treatment options
or develop resistance to available therapies.
This creates a lacuna, which in turn creates an
opportunity for the scientific community to
develop a keen interest in Intratumoral Cancer
Therapies that are immunotherapy's and the
immunization is administered directly into
tumor's through injections. By filling this
lacuna of cancer treatment, immunotherapy has
evolved and had come a long way with its benefits
and possesses advantages over conventional cancer
treatment methods, which is widely accepted.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
MARKET DYNAMICS

According to an estimate, 19,292,789 new cancer
cases were diagnosed worldwide with nearly
9,958,133 deaths due to cancers. Additionally,
according to estimates from the International
Agency for Research on Cancer (IARC), by 2040,
the global burden of cancers is expected to
continuously grow to 27.5 million new cancer
cases and 16.3 million deaths worldwide. This
rapid increment in the incidence of cancer cases
is predicted to drive the demand for advanced
cancer therapies for the effective treatment of
patients worldwide. Thus, according to the
above-mentioned factors, the cancer therapy as
well as intratumoral cancer therapies market is
predicted to witness tremendous growth over the
forecast period.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
REGIONAL INSIGHTS

In contemporary times, North America currently
dominates the Cancer Therapy Market and is
expected to continue during the forecast period.
In the future, North America is expected to
acquire more market share in the market due to
increased adoption of cancer therapy .According
to the report of GLOBOCAN 2020, an estimated
2,281,658 new cancer cases were diagnosed in the
United States in 2020, with nearly 612,390
deaths. In USA, the most common cancers were
breast (253,465), lung (227,875, colon (101,809)
and prostate (209,512) when observed in the year
2020. The statistics of the referred market
predict a positive outcome for the upcoming
investment in this field.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5
SEGMENTATION OF INTRATUMORAL CANCER THERAPIES
MARKET

There are different categories of Intramoral
therapies ranging from cytokines,
pathogen-associated molecular patterns (PAMPs),
oncolytic viruses, monoclonal antibodies, and
small molecules. The present Intratumoral cancer
therapy market comprises of three approved
therapies
Imlygic (talimogene laherparepvec
T-Vec) approved by FDA(USA) to treat melanoma
Hensify (NBTXR3) for the treatment of patients
suffering from soft tissue sarcoma
Delytact(teserpaturev) for the treatment of
malignant glioma
The intratumoral cancer therapies market has
registered the highest growth in North America
during the past few years and this progressive
trend is expected to continue in the forthcoming
years as well. This is a result of the growing
geriatric population.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
LEADING MARKET PLAYERS IN THE INDUSTRY

Some of the key/prominent /major players
operating in the Intratumoral Cancer market are
Checkmate Pharmaceuticals, OncoSec Medical
Incorporated, Merck, Istari Oncology, Replimune,
Philogen, Exicure, Sirnaomics, Nanobiotix,
Intensity Therapeutics, NanOlogy, Lokon Pharma,
Immunicum, DNAtrix, Treovir, Idera
Pharmaceuticals, and Immunovative Therapies among
others. These companies are working in the
contemporary times for the development of
Intratumoral cancer therapies at different stages
of clinical trials thereby boosting the
competition in the Intratumoral cancer market.
The emerging Intratumoral cancer therapies
pipeline is majorly curing melanoma, brain
cancer, nonmelanoma skin cancer, head, and neck
cancer.